Cite
Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma.
MLA
Zhewen Xiong, et al. “Targeting PPAR-Gamma Counteracts Tumour Adaptation to Immune-Checkpoint Blockade in Hepatocellular Carcinoma.” Gut, vol. 72, no. 9, Sept. 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1136/gutjnl-2022-328364.
APA
Zhewen Xiong, Chan, S. L., Jingying Zhou, Vong, J. S. L., Tsz Tung Kwong, Xuezhen Zeng, Haoran Wu, Jianquan Cao, Yalin Tu, Yu Feng, Weiqin Yang, Pak-Chun Wong, P., Willis Wai-Yiu Si-Tou, Xiaoyu Liu, Jing Wang, Wenshu Tang, Zhixian Liang, Jiahuan Lu, Ka Man Li, & Jie-Ting Low. (2023). Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma. Gut, 72(9), 1–16. https://doi.org/10.1136/gutjnl-2022-328364
Chicago
Zhewen Xiong, Stephen Lam Chan, Jingying Zhou, Joaquim S. L. Vong, Tsz Tung Kwong, Xuezhen Zeng, Haoran Wu, et al. 2023. “Targeting PPAR-Gamma Counteracts Tumour Adaptation to Immune-Checkpoint Blockade in Hepatocellular Carcinoma.” Gut 72 (9): 1–16. doi:10.1136/gutjnl-2022-328364.